INM — InMed Pharmaceuticals Share News
0.000.00%
Last trade - 00:00InMed Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary
Brief: InMed Pharmaceuticals Reports First Quarter Fiscal 2022 Financial Results
InMed Pharmaceuticals Inc expected to post a loss of 35 cents a share - Earnings Preview
Brief: InMed Pharmaceuticals Announces Commencement Of Phase 2 Clinical Trial Investigating Cannabinol In The Treatment Of Epidermolysis Bullosa
NASDAQ RESUMED AT 09:53 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:49 AM
U.S. STOCKS ON THE MOVE-Zivo Bioscience, Accenture, Carnival Corp
InMed Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
InMed Pharma gains on narrower-than-expected loss
InMed Pharmaceuticals Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: InMed Pharmaceuticals Signs Definitive Agreement To Acquire Baymedica
Brief: InMed Pharmaceuticals Files Prelim Prospectus Dated July 12 Related To Offering And Resale By Selling Shareholder Of Up To 8.1 Mln Shares
Brief: InMed Announces Closing Of US$12 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Brief: Inmed Pharmaceuticals Announces $12 Mln Private Placement Priced At-The-Market Under Nasdaq Rules
Brief: Inmed Pharmaceuticals Signs Non-Binding Letter Of Intent To Acquire Baymedica
Brief: Inmed Pharmaceuticals Increases Cannabinoid Yield To 5 G/L With Integrasyn™ In Advance Of Commercial Scale Production
InMed Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Brief: InMed Pharmaceuticals Reports Third Quarter Fiscal 2021 Financial Results
NASDAQ RESUMED AT 09:41 AM